Behcet Disease (Behçet disease) Therapeutics Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

CITY, Country, 2019-Jul-16 — /EPR Network/ —

Behcet Disease (Behçet disease) is an inflammatory disorder that affects blood vessels of various body parts including mouth, genitals, skin, and eyes. Some of the symptoms of this disease are mouth sores, skin sores, genital sores, uveitis, joint swelling, abdominal pain, headache, and fever.

Download the sample report at: https://www.pharmaproff.com/request-sample/1001

Usually, painful mouth ulcers are the first sign of the disease observed in the patients. The cause of the disease is still unknown, but variation in the HLA-B gene is observed in patients suffering from this disease.

Get the detailed analysis at: https://www.pharmaproff.com/report/behcet-disease-therapeutics-pipeline-analysis

Other than genetic factors, environmental factors, such as bacterial and viral infections are also known to trigger the occurrence of Behcet Disease. Celgene Corporation is in the process of developing OTEZLA, an interleukin 23 inhibitor for the treatment of Behcet disease.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1001

Also, JN Biosciences LLC is in the process of developing HuABC2 as an anti-CD122 antibody for the treatment of Behcet disease. Some of the companies involved in the pipeline of Behcet disease include Alexion Pharmaceuticals Inc., and Omeros Corporation among others.

  • The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
  • Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com

Web: https://www.pharmaproff.com

Connect with us on: LinkedIn | Twitter | Facebook

Matched content

Editor’s pick